QSS
AMPH icon

Quantitative Systematic Strategies’s Amphastar Pharmaceuticals AMPH Stock Holding History

Quantitative Systematic Strategies’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17,933
Closed -$403K – 583
2020
Q2 		$403K Buy
+17,933
New +$328K 0.08% 352

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Quantitative Systematic Strategies's AMPH Position: Q3 2020 in Review

Quantitative Systematic Strategies sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2020, closing a stake of 17,933 shares — an estimated $403K sold.

Quantitative Systematic Strategies first reported a position in AMPH in Q2 2020 and held it in 1 quarter. The position peaked at $403K in Q2 2020. 136 funds tracked by Wall St. Rank hold AMPH as of Q3 2020.

  • Quantitative Systematic Strategies reported no remaining Amphastar Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 17,933 Amphastar Pharmaceuticals shares in Q3 2020, an estimated $403K.
  • Quantitative Systematic Strategies first reported a position in Amphastar Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Amphastar Pharmaceuticals position peaked at $403K in Q2 2020.
  • 136 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2020, filed 9 Nov 2020.